Sheldon Brown: 1944 - 2008
BikeRadar.com - Bath,UK
The 63-year-old bicycle expert was diagnosed with primary progressive multiple sclerosis in August 2007, limiting his prior upright bicycling and workload. ...
See all stories on this topic

Half Year Accounts - 31 December 2007
Sydney Morning Herald - Sydney,New South Wales,Australia
ATL1102 for Multiple Sclerosis ATL1102 is a second generation antisense inhibitor of CD49d, a subunit of VLA-4 (Very Late Antigen-4). ...
See all stories on this topic

Earnings Preview: Biogen Idec
Houston Chronicle - United States
Other developments in the quarter included the company's continued monitoring and expanded development of the multiple sclerosis drug Tysabri. ...
See all stories on this topic

STEM the damage
Deccan Herald - Bangalore,India
Researchers at the Manipal Institute of Regenerative Medicine and Stempeutics have come up with a way of designing safer drugs and understanding their ...
See all stories on this topic

Doctors treat MS sufferers with cannabis
The Scotsman Sat, 02 Feb 2008 4:24 PM PST
SCOTTISH doctors have started prescribing cannabis on the NHS before it is officially licensed in a bid to relieve the pain of multiple sclerosis sufferers.

Of mice, molecules and music
Jerusalem Post - Israel
"We will have better ways of arresting the course of the disease, such as by using regenerative medicine with stem cells that could bring back function. ...
See all stories on this topic

Pipex Pharmaceuticals Announces First Notice of Allowance for US ...
CNNMoney.com - USA
Pipex's product candidate TRIMESTA (oral, once-daily estriol), which is covered by this notice of allowance, is currently in a Phase III multi-center, ...
See all stories on this topic

Pipex Pharmaceuticals Announces First Notice of Allowance for US ...
FOXBusiness - USA
Pipex's product candidate TRIMESTA (oral, once-daily estriol), which is covered by this notice of allowance, is currently in a Phase III multi-center, ...
See all stories on this topic

Montel Quits Show To Explode Teenagers Full-Time
hecklerspray - Los Angeles,USA
Or perhaps Montel Williams is no longer able to balance the stress of hosting his own TV show with his ongoing battle with Multiple Sclerosis. ...
See all stories on this topic

All Talked Out: Montel Williams Ends 17-Year Daytime Talk Show
Blackvoices - USA
Since debuting in 1991, the Emmy-winning talk show host was diagnosed with Multiple Sclerosis and launched his Montel Williams MS Foundation to raise ...
See all stories on this topic

Montel Williams' Talk Show to End After 17 Years On-Air
BlackNews.com (press release) - Columbus,OH,USA
His New York Times best-selling autobiography, "Climbing Higher," was published in January 2004 and details his struggle with Multiple Sclerosis. ...
See all stories on this topic

Montel to End His Show after Nearly Two Decades
eFluxMedia - USA
By Jane Ivory “The Montel Williams Show” will end its 17-year career on CBS at the end of this season, it was announced Wednesday. ...
See all stories on this topic

Acorda Therapeutics Announces Acquisition of Aminopyridine and Pre ...
PR-Inside.com (Pressemitteilung) - Wien,Austria
This acquisition will enable Acorda to explore additional therapeutic indications for its investigational compound Fampridine-SR, as well as gain access to ...
See all stories on this topic

Search the Lower Hudson area:
Business in the Burbs - White Plains,NY,USA
Acorda said the acquisition will allow it to explore additional uses for its Fampridine-SR, a drug it is develping. Acorda issued 100000 shares of its stock ...
See all stories on this topic

Four Days Of REM Sleep Deprivation Contributes To A Reduction Of Cell Proliferation In Rats
Four days' exposure to a REM sleep deprivation procedure reduces cell proliferation in the part of the forebrain that contributes to long-term memory of rats. The study, authored by Dennis McGinty, PhD, of the V.

Stem Cell deal targets treatment for MS
The Herald - Glasgow,Scotland,UK
... for multiple sclerosis. The Alternative Investment Market-listed company said it could have access to sustainable sources of uniform human brain cells ...
See all stories on this topic

Island woman heads to China for MS treatment
ChronicleHerald.ca - Halifax,Nova Scotia,Canada
... this month to get medical treatment for her multiple sclerosis. She’s going to the Stem Cell Centre at Nanshan Hospital to get stem cell injections, ...
See all stories on this topic

BikeRadar.com - Bath,UK
The 63-year-old bicycle expert was diagnosed with primary progressive multiple sclerosis in August 2007, limiting his prior upright bicycling and workload. ...
See all stories on this topic

Half Year Accounts - 31 December 2007
Sydney Morning Herald - Sydney,New South Wales,Australia
ATL1102 for Multiple Sclerosis ATL1102 is a second generation antisense inhibitor of CD49d, a subunit of VLA-4 (Very Late Antigen-4). ...
See all stories on this topic

Earnings Preview: Biogen Idec
Houston Chronicle - United States
Other developments in the quarter included the company's continued monitoring and expanded development of the multiple sclerosis drug Tysabri. ...
See all stories on this topic

STEM the damage
Deccan Herald - Bangalore,India
Researchers at the Manipal Institute of Regenerative Medicine and Stempeutics have come up with a way of designing safer drugs and understanding their ...
See all stories on this topic

Doctors treat MS sufferers with cannabis
The Scotsman Sat, 02 Feb 2008 4:24 PM PST
SCOTTISH doctors have started prescribing cannabis on the NHS before it is officially licensed in a bid to relieve the pain of multiple sclerosis sufferers.

Of mice, molecules and music
Jerusalem Post - Israel
"We will have better ways of arresting the course of the disease, such as by using regenerative medicine with stem cells that could bring back function. ...
See all stories on this topic

Pipex Pharmaceuticals Announces First Notice of Allowance for US ...
CNNMoney.com - USA
Pipex's product candidate TRIMESTA (oral, once-daily estriol), which is covered by this notice of allowance, is currently in a Phase III multi-center, ...
See all stories on this topic

Pipex Pharmaceuticals Announces First Notice of Allowance for US ...
FOXBusiness - USA
Pipex's product candidate TRIMESTA (oral, once-daily estriol), which is covered by this notice of allowance, is currently in a Phase III multi-center, ...
See all stories on this topic

Montel Quits Show To Explode Teenagers Full-Time
hecklerspray - Los Angeles,USA
Or perhaps Montel Williams is no longer able to balance the stress of hosting his own TV show with his ongoing battle with Multiple Sclerosis. ...
See all stories on this topic

All Talked Out: Montel Williams Ends 17-Year Daytime Talk Show
Blackvoices - USA
Since debuting in 1991, the Emmy-winning talk show host was diagnosed with Multiple Sclerosis and launched his Montel Williams MS Foundation to raise ...
See all stories on this topic

Montel Williams' Talk Show to End After 17 Years On-Air
BlackNews.com (press release) - Columbus,OH,USA
His New York Times best-selling autobiography, "Climbing Higher," was published in January 2004 and details his struggle with Multiple Sclerosis. ...
See all stories on this topic

Montel to End His Show after Nearly Two Decades
eFluxMedia - USA
By Jane Ivory “The Montel Williams Show” will end its 17-year career on CBS at the end of this season, it was announced Wednesday. ...
See all stories on this topic

Acorda Therapeutics Announces Acquisition of Aminopyridine and Pre ...
PR-Inside.com (Pressemitteilung) - Wien,Austria
This acquisition will enable Acorda to explore additional therapeutic indications for its investigational compound Fampridine-SR, as well as gain access to ...
See all stories on this topic

Search the Lower Hudson area:
Business in the Burbs - White Plains,NY,USA
Acorda said the acquisition will allow it to explore additional uses for its Fampridine-SR, a drug it is develping. Acorda issued 100000 shares of its stock ...
See all stories on this topic

Four Days Of REM Sleep Deprivation Contributes To A Reduction Of Cell Proliferation In Rats
Four days' exposure to a REM sleep deprivation procedure reduces cell proliferation in the part of the forebrain that contributes to long-term memory of rats. The study, authored by Dennis McGinty, PhD, of the V.

Stem Cell deal targets treatment for MS
The Herald - Glasgow,Scotland,UK
... for multiple sclerosis. The Alternative Investment Market-listed company said it could have access to sustainable sources of uniform human brain cells ...
See all stories on this topic

Island woman heads to China for MS treatment
ChronicleHerald.ca - Halifax,Nova Scotia,Canada
... this month to get medical treatment for her multiple sclerosis. She’s going to the Stem Cell Centre at Nanshan Hospital to get stem cell injections, ...
See all stories on this topic